Hollow crystalline straws of diclofenac for high-dose and carrier-free dry powder inhaler formulations

[Display omitted] To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled formulations From the acidic titration of aqueous DFNa, DF crystals were formed and were identified using thermal analysis, spe...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 502; no. 1-2; pp. 170 - 180
Main Authors Yazdi, Ashkan K., Smyth, Hugh D.C.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 11.04.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract [Display omitted] To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled formulations From the acidic titration of aqueous DFNa, DF crystals were formed and were identified using thermal analysis, spectroscopy, and X-ray powder diffraction. Following the micronization of the DF and DFNa powders, the recovered samples were imaged, and their particle size distributions were evaluated. Samples before and after jet millings were characterized, and in vitro aerodynamic performance testing was performed on the DF sample before jet milling and the DF and DFNa samples following jet milling. Hollow needles of DF were precipitated. With similar particle size distributions, the jet-milled DFNa sample from the collection bag, and the DF sample from the cyclone were used for further characterization. Despite different deposition patterns in the Next Generation Impactor, the DF hollow needles had a comparable respirable fraction percentage to the jet-milled DF and DFNa particles. However, the jet-milled DF formulation had the best in vitro aerodynamic performance. Hollow, crystalline needles of DF were formed and possessed promising aerosol performance in comparison with the jet-milled powders.
AbstractList To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled formulations From the acidic titration of aqueous DFNa, DF crystals were formed and were identified using thermal analysis, spectroscopy, and X-ray powder diffraction. Following the micronization of the DF and DFNa powders, the recovered samples were imaged, and their particle size distributions were evaluated. Samples before and after jet millings were characterized, and in vitro aerodynamic performance testing was performed on the DF sample before jet milling and the DF and DFNa samples following jet milling. Hollow needles of DF were precipitated. With similar particle size distributions, the jet-milled DFNa sample from the collection bag, and the DF sample from the cyclone were used for further characterization. Despite different deposition patterns in the Next Generation Impactor, the DF hollow needles had a comparable respirable fraction percentage to the jet-milled DF and DFNa particles. However, the jet-milled DF formulation had the best in vitro aerodynamic performance. Hollow, crystalline needles of DF were formed and possessed promising aerosol performance in comparison with the jet-milled powders.
OBJECTIVETo crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled formulationsMATERIALS AND METHODSFrom the acidic titration of aqueous DFNa, DF crystals were formed and were identified using thermal analysis, spectroscopy, and X-ray powder diffraction. Following the micronization of the DF and DFNa powders, the recovered samples were imaged, and their particle size distributions were evaluated. Samples before and after jet millings were characterized, and in vitro aerodynamic performance testing was performed on the DF sample before jet milling and the DF and DFNa samples following jet milling.RESULTS AND DISCUSSIONHollow needles of DF were precipitated. With similar particle size distributions, the jet-milled DFNa sample from the collection bag, and the DF sample from the cyclone were used for further characterization. Despite different deposition patterns in the Next Generation Impactor, the DF hollow needles had a comparable respirable fraction percentage to the jet-milled DF and DFNa particles. However, the jet-milled DF formulation had the best in vitro aerodynamic performance.CONCLUSIONSHollow, crystalline needles of DF were formed and possessed promising aerosol performance in comparison with the jet-milled powders.
[Display omitted] To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled formulations From the acidic titration of aqueous DFNa, DF crystals were formed and were identified using thermal analysis, spectroscopy, and X-ray powder diffraction. Following the micronization of the DF and DFNa powders, the recovered samples were imaged, and their particle size distributions were evaluated. Samples before and after jet millings were characterized, and in vitro aerodynamic performance testing was performed on the DF sample before jet milling and the DF and DFNa samples following jet milling. Hollow needles of DF were precipitated. With similar particle size distributions, the jet-milled DFNa sample from the collection bag, and the DF sample from the cyclone were used for further characterization. Despite different deposition patterns in the Next Generation Impactor, the DF hollow needles had a comparable respirable fraction percentage to the jet-milled DF and DFNa particles. However, the jet-milled DF formulation had the best in vitro aerodynamic performance. Hollow, crystalline needles of DF were formed and possessed promising aerosol performance in comparison with the jet-milled powders.
Author Yazdi, Ashkan K.
Smyth, Hugh D.C.
Author_xml – sequence: 1
  givenname: Ashkan K.
  surname: Yazdi
  fullname: Yazdi, Ashkan K.
  email: ashkan.k.yazdi@utexas.edu, ashkan.k.yazdi@gmail.com
– sequence: 2
  givenname: Hugh D.C.
  surname: Smyth
  fullname: Smyth, Hugh D.C.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26911418$$D View this record in MEDLINE/PubMed
BookMark eNqFkEtrWzEQhUVJaBynP6FFy2zujR73uQol5AWBbpq1GEujWkZXcqTrGv_7KNjtNsziMHDOHOa7JGchBiTkO2c1Z7y72dRus11DmmpR1pqJmkn2hSz40MtKNn13RhZM9kPV8l5ekMucN4yxTnD5lVyIbuS84cOC2KfofdxTnQ55Bu9dQJrnBPtMo6XGaR8tBtDUxkTX7s-6MjEjhWCohpQcpsomRGrSgW7j3mCiLqzBFy2JaedhdjHkK3JuwWf8dtIleX24_333VL38eny--_lS6UbyuRJyJbUdesEGzrTBxlomutUIrANhpB05jDCiBY4wDNDYFphFLoVpYeBtL5fk-nh3m-LbDvOsJpc1eg8B4y4r3vdNK2VbZknao1WnmHNCq7bJTZAOijP1gVht1Amx-kCsmFAFccn9OFXsVhOa_6l_TIvh9mjA8ujfQkhl7TBoNC6hnpWJ7pOKd6DKk24
CitedBy_id crossref_primary_10_1021_acsabm_3c00162
crossref_primary_10_1021_acs_molpharmaceut_8b00907
crossref_primary_10_3390_ma11050864
crossref_primary_10_1016_j_ijpharm_2022_121914
crossref_primary_10_1016_j_powtec_2020_08_063
crossref_primary_10_1016_j_apt_2020_03_028
crossref_primary_10_1016_j_ijpharm_2021_121259
crossref_primary_10_1016_j_ijpharm_2017_06_002
crossref_primary_10_1016_j_ijpharm_2021_120568
crossref_primary_10_1007_s40199_024_00520_3
crossref_primary_10_1021_acs_cgd_9b00292
crossref_primary_10_1016_j_molstruc_2020_128066
crossref_primary_10_1016_j_saa_2021_120018
crossref_primary_10_1021_acs_molpharmaceut_7b00690
crossref_primary_10_1021_acs_cgd_7b00099
crossref_primary_10_1208_s12249_022_02480_w
crossref_primary_10_1016_j_ijpharm_2018_07_065
crossref_primary_10_1021_acs_molpharmaceut_9b01085
crossref_primary_10_1016_j_ijpharm_2018_05_036
crossref_primary_10_3390_pharmaceutics15020674
crossref_primary_10_3390_pharmaceutics13010031
crossref_primary_10_3390_pharmaceutics15122706
Cites_doi 10.1016/j.ijpharm.2011.05.043
10.1107/S0108270197002126
10.1016/j.ijpharm.2008.04.044
10.1378/chest.124.1.360
10.1021/cg900969n
10.1152/physrev.00004.2008
10.1007/s11095-007-9475-1
10.1046/j.1365-2125.2003.01892.x
10.1016/j.ijpharm.2012.03.020
10.1146/annurev.pa.33.040193.002251
10.1208/s12249-010-9542-5
10.1134/S1990793110070018
10.1177/193229681200600406
10.1016/S0168-3659(02)00460-1
10.1183/09031936.00071312
10.3810/psm.2013.05.2016
10.1016/j.jcrysgro.2011.10.060
10.3164/jcbn.10-79
10.1002/jps.20943
10.1007/s11095-010-0215-6
10.1016/S0140-6736(94)91843-0
10.1016/j.ijpharm.2003.10.039
10.1246/cl.2005.1422
10.1016/0584-8539(95)01479-9
10.1021/la100449z
10.1590/S0104-66322008000200016
10.1021/jm0612970
ContentType Journal Article
Copyright 2016 Elsevier B.V.
Copyright © 2016 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2016 Elsevier B.V.
– notice: Copyright © 2016 Elsevier B.V. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ijpharm.2016.02.030
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-3476
EndPage 180
ExternalDocumentID 10_1016_j_ijpharm_2016_02_030
26911418
S0378517316301235
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
5GY
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSP
SSZ
T5K
TEORI
~02
~G-
AAQFI
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
.GJ
29J
3O-
53G
5VS
AAQXK
AAYXX
ABXDB
ADMUD
AFJKZ
ASPBG
AVWKF
AZFZN
CITATION
FEDTE
FGOYB
G-2
HMT
HVGLF
HZ~
R2-
SEW
SPT
WUQ
ZXP
7X8
ID FETCH-LOGICAL-c431t-23b3cf8720810cde4ff026b9a06a2d3f91a9a9efa1ea88a4f5a0fe132d5a81573
IEDL.DBID .~1
ISSN 0378-5173
IngestDate Sat Oct 26 01:39:00 EDT 2024
Thu Sep 26 16:34:30 EDT 2024
Sat Sep 28 07:57:50 EDT 2024
Fri Feb 23 02:34:25 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1-2
Keywords ρ
DF
FT-IR
DFNa
HR
Jet milling
XRD
Diclofenac sodium (PubChem CID: 5018304)
Diclofenac
HCl
FPF5μm
Precipitation
FPF3μm
Sodium dodecyl sulfate (PubChem CID: 3423265
DSC
Next generation impactor
GSD
Tween 20 (PubChem CID: 443314)
FPF1μm
ED
SSA
MOC
Diclofenac (PubChem CID: 3033)
Dry powder inhaler
ρB
CI
MMAD
BET
NGI
USP
ρT
RF
Diclofenac sodium
SEM
FPF
HPMC
Language English
License Copyright © 2016 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c431t-23b3cf8720810cde4ff026b9a06a2d3f91a9a9efa1ea88a4f5a0fe132d5a81573
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 26911418
PQID 1774533535
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_1774533535
crossref_primary_10_1016_j_ijpharm_2016_02_030
pubmed_primary_26911418
elsevier_sciencedirect_doi_10_1016_j_ijpharm_2016_02_030
PublicationCentury 2000
PublicationDate 2016-04-11
PublicationDateYYYYMMDD 2016-04-11
PublicationDate_xml – month: 04
  year: 2016
  text: 2016-04-11
  day: 11
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle International journal of pharmaceutics
PublicationTitleAlternate Int J Pharm
PublicationYear 2016
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Boss, Petrucci, Lorber (bib0015) 2012; 6
Llinàs, Burley, Box, Glen, Goodman (bib0095) 2007; 50
Eddleston, Jones (bib0040) 2010; 10
USP General Chapter (bib0145) 2015
USP General Chapter (bib0150) 2015
Zalepugin, Tilkunova, Fronchek, Gallyamov, Chernyshova, Mishin, Yashin, Grigoryev, Gamzazade, Khokhlov (bib0185) 2010; 4
Labiris, Dolovich (bib0085) 2003
Klinge, Sawyer (bib0075) 2013; 41
Yazdi, Smyth (bib0180) 2015
Hira, Okuda, Kito, Ishizeki, Okada, Okamoto (bib0055) 2010; 27
Murray, Brater (bib0105) 1993; 33
Shariare, de Matas, York (bib0130) 2011; 415
Cabaniss, McVey (bib0020) 1995; 51
Xiao, Liu, Mi, Yuan, Zhang, Cheng (bib0175) 2005; 34
Newhouse, Hirst, Duddu, Walter, Tarara, Clark, Weers (bib0110) 2003; 124
Center for Drug Evaluation Research (bib0030)
Hinds (bib0050) 2012
Rodriguez, Jick (bib0120) 1994; 343
Telko, Hickey (bib0140) 2005; 50
Hickey, Mansour, Telko, Xu, Smyth, Mulder, McLean, Langridge, Papadopoulos (bib0045) 2007; 96
Lexi-Comp Inc., 2015. Diclofenac [WWW Document] (accessed 08.26.15.).
Bae, Yazaydın, Snurr (bib0005) 2010; 26
Kubavat, Shur, Ruecroft, Hipkiss, Price (bib0080) 2012; 430
Dodd, A., Meiser, F., Norret, M., Russell, A., Bosch, H.W., 2014. Formulation of diclofenac. US8679544 B2.
Beck, Lionzo, Costa, Benvenutti, Ré, Gallas, Pohlmann, Guterres (bib0010) 2008; 25
Iroko Pharmaceuticals, LLC, 2013. Zorvolex (R) [package insert].
Steckel, Bolzen (bib0135) 2004; 270
Novartis, 2013. Tobi Podhaler (R) [Package insert].
Saleem, Smyth (bib0125) 2010; 11
Vehring (bib0160) 2008; 25
Castellari, Ottani (bib0025) 1997; 53
Ikegami, Kawashima, Takeuchi, Yamamoto, Mimura, Mamose, Ouchi (bib0060) 2003; 88
Wallace (bib0165) 2008; 88
Wilson, Welte, Polverino, Soyza, Greville, ODonnell, Alder, Reimnitz, Hampel (bib0170) 2013; 41
Ulrich, Schuster, Stelzer (bib0155) 2013; 362
Matsui, Shimokawa, Kaneko, Nagano, Rai, Hyodo (bib0100) 2011; 48
Islam, Gladki (bib0070) 2008; 360
Center for Drug Evaluation Research (10.1016/j.ijpharm.2016.02.030_bib0030)
Beck (10.1016/j.ijpharm.2016.02.030_bib0010) 2008; 25
Yazdi (10.1016/j.ijpharm.2016.02.030_bib0180) 2015
10.1016/j.ijpharm.2016.02.030_bib0065
Steckel (10.1016/j.ijpharm.2016.02.030_bib0135) 2004; 270
Hinds (10.1016/j.ijpharm.2016.02.030_bib0050) 2012
Kubavat (10.1016/j.ijpharm.2016.02.030_bib0080) 2012; 430
Ulrich (10.1016/j.ijpharm.2016.02.030_bib0155) 2013; 362
10.1016/j.ijpharm.2016.02.030_bib0115
Bae (10.1016/j.ijpharm.2016.02.030_bib0005) 2010; 26
Zalepugin (10.1016/j.ijpharm.2016.02.030_bib0185) 2010; 4
Hira (10.1016/j.ijpharm.2016.02.030_bib0055) 2010; 27
Llinàs (10.1016/j.ijpharm.2016.02.030_bib0095) 2007; 50
Shariare (10.1016/j.ijpharm.2016.02.030_bib0130) 2011; 415
Wallace (10.1016/j.ijpharm.2016.02.030_bib0165) 2008; 88
Ikegami (10.1016/j.ijpharm.2016.02.030_bib0060) 2003; 88
Hickey (10.1016/j.ijpharm.2016.02.030_bib0045) 2007; 96
Telko (10.1016/j.ijpharm.2016.02.030_bib0140) 2005; 50
Klinge (10.1016/j.ijpharm.2016.02.030_bib0075) 2013; 41
USP General Chapter (10.1016/j.ijpharm.2016.02.030_bib0145) 2015
Vehring (10.1016/j.ijpharm.2016.02.030_bib0160) 2008; 25
Wilson (10.1016/j.ijpharm.2016.02.030_bib0170) 2013; 41
10.1016/j.ijpharm.2016.02.030_bib0090
Saleem (10.1016/j.ijpharm.2016.02.030_bib0125) 2010; 11
10.1016/j.ijpharm.2016.02.030_bib0035
USP General Chapter (10.1016/j.ijpharm.2016.02.030_bib0150) 2015
Cabaniss (10.1016/j.ijpharm.2016.02.030_bib0020) 1995; 51
Matsui (10.1016/j.ijpharm.2016.02.030_bib0100) 2011; 48
Newhouse (10.1016/j.ijpharm.2016.02.030_bib0110) 2003; 124
Xiao (10.1016/j.ijpharm.2016.02.030_bib0175) 2005; 34
Castellari (10.1016/j.ijpharm.2016.02.030_bib0025) 1997; 53
Eddleston (10.1016/j.ijpharm.2016.02.030_bib0040) 2010; 10
Labiris (10.1016/j.ijpharm.2016.02.030_bib0085) 2003
Murray (10.1016/j.ijpharm.2016.02.030_bib0105) 1993; 33
Boss (10.1016/j.ijpharm.2016.02.030_bib0015) 2012; 6
Islam (10.1016/j.ijpharm.2016.02.030_bib0070) 2008; 360
Rodriguez (10.1016/j.ijpharm.2016.02.030_bib0120) 1994; 343
References_xml – volume: 10
  start-page: 365
  year: 2010
  end-page: 370
  ident: bib0040
  article-title: Formation of tubular crystals of pharmaceutical compounds
  publication-title: Cryst. Growth Des.
  contributor:
    fullname: Jones
– start-page: 588
  year: 2003
  end-page: 599
  ident: bib0085
  article-title: Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications
  publication-title: Br. J. Clin. Pharmacol.
  contributor:
    fullname: Dolovich
– year: 2012
  ident: bib0050
  article-title: Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles
  contributor:
    fullname: Hinds
– volume: 360
  start-page: 1
  year: 2008
  end-page: 11
  ident: bib0070
  article-title: Dry powder inhalers (DPIs)—a review of device reliability and innovation
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Gladki
– volume: 53
  start-page: 794
  year: 1997
  end-page: 797
  ident: bib0025
  article-title: Two monoclinic forms of diclofenac acid
  publication-title: Acta Crystallogr. Sect. C
  contributor:
    fullname: Ottani
– volume: 33
  start-page: 435
  year: 1993
  end-page: 465
  ident: bib0105
  article-title: Renal toxicity of the nonsteroidal anti-Inflammatory drugs
  publication-title: Annu. Rev. Pharmacol. Toxicol.
  contributor:
    fullname: Brater
– start-page: 523
  year: 2015
  end-page: 528
  ident: bib0180
  article-title: Effect of capsule fill weight on device resistance in dry powder inhalers
  publication-title: Respiratory Drug Delivery
  contributor:
    fullname: Smyth
– volume: 25
  start-page: 389
  year: 2008
  end-page: 398
  ident: bib0010
  article-title: Surface morphology of spray-dried nanoparticle-coated microparticles designed as an oral drug delivery system
  publication-title: Braz. J. Chem. Eng.
  contributor:
    fullname: Guterres
– volume: 48
  start-page: 107
  year: 2011
  end-page: 111
  ident: bib0100
  article-title: The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine
  publication-title: J. Clin. Biochem. Nutr.
  contributor:
    fullname: Hyodo
– ident: bib0030
  article-title: Drug Safety and Availability-FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes [WWW Document]
  contributor:
    fullname: Center for Drug Evaluation Research
– volume: 25
  start-page: 999
  year: 2008
  end-page: 1022
  ident: bib0160
  article-title: Pharmaceutical particle engineering via spray drying
  publication-title: Pharm. Res.
  contributor:
    fullname: Vehring
– volume: 88
  start-page: 23
  year: 2003
  end-page: 33
  ident: bib0060
  article-title: A new agglomerated KSR-592 beta-form crystal system for dry powder inhalation formulation to improve inhalation performance in vitro and in vivo
  publication-title: J. Controlled Release
  contributor:
    fullname: Ouchi
– start-page: 1326
  year: 2015
  end-page: 1330
  ident: bib0145
  article-title: Powder flow
  publication-title: US Pharmacopeial Convention
  contributor:
    fullname: USP General Chapter <1174>
– volume: 11
  start-page: 1642
  year: 2010
  end-page: 1649
  ident: bib0125
  article-title: Micronization of a soft material: air-Jet and micro-Ball milling
  publication-title: AAPS PharmSciTech
  contributor:
    fullname: Smyth
– volume: 270
  start-page: 297
  year: 2004
  end-page: 306
  ident: bib0135
  article-title: Alternative sugars as potential carriers for dry powder inhalations
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Bolzen
– start-page: 388
  year: 2015
  end-page: 414
  ident: bib0150
  article-title: Inhalation and nasal drug products: aerosols, sprays, and powders – performance quality tests
  publication-title: US Pharmacopeial Convention
  contributor:
    fullname: USP General Chapter <601>
– volume: 51
  start-page: 2385
  year: 1995
  end-page: 2395
  ident: bib0020
  article-title: Aqueous infrared carboxylate absorbances: aliphatic monocarboxylates
  publication-title: Spectrochim. Acta. A. Mol. Biomol. Spectrosc.
  contributor:
    fullname: McVey
– volume: 124
  start-page: 360
  year: 2003
  end-page: 366
  ident: bib0110
  article-title: Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers
  publication-title: Chest
  contributor:
    fullname: Weers
– volume: 96
  start-page: 1302
  year: 2007
  end-page: 1319
  ident: bib0045
  article-title: Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics
  publication-title: J. Pharm. Sci.
  contributor:
    fullname: Papadopoulos
– volume: 26
  start-page: 5475
  year: 2010
  end-page: 5483
  ident: bib0005
  article-title: Evaluation of the BET method for determining surface areas of MOFs and zeolites that contain ultra-Micropores
  publication-title: Langmuir
  contributor:
    fullname: Snurr
– volume: 430
  start-page: 26
  year: 2012
  end-page: 33
  ident: bib0080
  article-title: Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Price
– volume: 343
  start-page: 769
  year: 1994
  ident: bib0120
  article-title: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal
  publication-title: Lancet
  contributor:
    fullname: Jick
– volume: 27
  start-page: 2131
  year: 2010
  end-page: 2140
  ident: bib0055
  article-title: Inhalation performance of physically mixed dry powders evaluated with a simple simulator for human inspiratory flow patterns
  publication-title: Pharm. Res.
  contributor:
    fullname: Okamoto
– volume: 362
  start-page: 235
  year: 2013
  end-page: 237
  ident: bib0155
  article-title: Crystalline coats or hollow crystals as tools for product design in pharmaceutical industry
  publication-title: J. Cryst. Growth
  contributor:
    fullname: Stelzer
– volume: 415
  start-page: 62
  year: 2011
  end-page: 72
  ident: bib0130
  article-title: Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate
  publication-title: Int. J. Pharm.
  contributor:
    fullname: York
– volume: 88
  start-page: 1547
  year: 2008
  end-page: 1565
  ident: bib0165
  article-title: Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself?
  publication-title: Physiol. Rev.
  contributor:
    fullname: Wallace
– volume: 50
  start-page: 979
  year: 2007
  end-page: 983
  ident: bib0095
  article-title: Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms
  publication-title: J. Med. Chem.
  contributor:
    fullname: Goodman
– volume: 4
  start-page: 1047
  year: 2010
  end-page: 1050
  ident: bib0185
  article-title: Production of new haemostatic materials by deposition of dispersed proteins onto porous matrices using supercritical carbon dioxide
  publication-title: Russ. J. Phys. Chem. B
  contributor:
    fullname: Khokhlov
– volume: 41
  start-page: 64
  year: 2013
  end-page: 74
  ident: bib0075
  article-title: Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review
  publication-title: Phys. Sportsmed.
  contributor:
    fullname: Sawyer
– volume: 50
  start-page: 1209
  year: 2005
  end-page: 1227
  ident: bib0140
  article-title: Dry powder inhaler formulation
  publication-title: Respir. Care
  contributor:
    fullname: Hickey
– volume: 34
  start-page: 1422
  year: 2005
  end-page: 1423
  ident: bib0175
  article-title: A simple route to form straw-like carbon microbundles
  publication-title: Chem. Lett.
  contributor:
    fullname: Cheng
– volume: 6
  start-page: 773
  year: 2012
  end-page: 779
  ident: bib0015
  article-title: Coverage of prandial insulin requirements by means of an ultra-Rapid-Acting inhaled insulin
  publication-title: J. Diabetes Sci. Technol.
  contributor:
    fullname: Lorber
– volume: 41
  start-page: 1107
  year: 2013
  end-page: 1115
  ident: bib0170
  article-title: Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
  publication-title: Eur. Respir. J.
  contributor:
    fullname: Hampel
– volume: 50
  start-page: 1209
  year: 2005
  ident: 10.1016/j.ijpharm.2016.02.030_bib0140
  article-title: Dry powder inhaler formulation
  publication-title: Respir. Care
  contributor:
    fullname: Telko
– volume: 415
  start-page: 62
  year: 2011
  ident: 10.1016/j.ijpharm.2016.02.030_bib0130
  article-title: Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2011.05.043
  contributor:
    fullname: Shariare
– volume: 53
  start-page: 794
  year: 1997
  ident: 10.1016/j.ijpharm.2016.02.030_bib0025
  article-title: Two monoclinic forms of diclofenac acid
  publication-title: Acta Crystallogr. Sect. C
  doi: 10.1107/S0108270197002126
  contributor:
    fullname: Castellari
– volume: 360
  start-page: 1
  year: 2008
  ident: 10.1016/j.ijpharm.2016.02.030_bib0070
  article-title: Dry powder inhalers (DPIs)—a review of device reliability and innovation
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2008.04.044
  contributor:
    fullname: Islam
– start-page: 523
  year: 2015
  ident: 10.1016/j.ijpharm.2016.02.030_bib0180
  article-title: Effect of capsule fill weight on device resistance in dry powder inhalers
  contributor:
    fullname: Yazdi
– year: 2012
  ident: 10.1016/j.ijpharm.2016.02.030_bib0050
  contributor:
    fullname: Hinds
– volume: 124
  start-page: 360
  year: 2003
  ident: 10.1016/j.ijpharm.2016.02.030_bib0110
  article-title: Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers
  publication-title: Chest
  doi: 10.1378/chest.124.1.360
  contributor:
    fullname: Newhouse
– volume: 10
  start-page: 365
  year: 2010
  ident: 10.1016/j.ijpharm.2016.02.030_bib0040
  article-title: Formation of tubular crystals of pharmaceutical compounds
  publication-title: Cryst. Growth Des.
  doi: 10.1021/cg900969n
  contributor:
    fullname: Eddleston
– start-page: 1326
  year: 2015
  ident: 10.1016/j.ijpharm.2016.02.030_bib0145
  article-title: Powder flow
  contributor:
    fullname: USP General Chapter <1174>
– volume: 88
  start-page: 1547
  year: 2008
  ident: 10.1016/j.ijpharm.2016.02.030_bib0165
  article-title: Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself?
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00004.2008
  contributor:
    fullname: Wallace
– ident: 10.1016/j.ijpharm.2016.02.030_bib0115
– start-page: 388
  year: 2015
  ident: 10.1016/j.ijpharm.2016.02.030_bib0150
  article-title: Inhalation and nasal drug products: aerosols, sprays, and powders – performance quality tests
  contributor:
    fullname: USP General Chapter <601>
– volume: 25
  start-page: 999
  year: 2008
  ident: 10.1016/j.ijpharm.2016.02.030_bib0160
  article-title: Pharmaceutical particle engineering via spray drying
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-007-9475-1
  contributor:
    fullname: Vehring
– start-page: 588
  year: 2003
  ident: 10.1016/j.ijpharm.2016.02.030_bib0085
  article-title: Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications
  publication-title: Br. J. Clin. Pharmacol.
  doi: 10.1046/j.1365-2125.2003.01892.x
  contributor:
    fullname: Labiris
– ident: 10.1016/j.ijpharm.2016.02.030_bib0030
  contributor:
    fullname: Center for Drug Evaluation Research
– volume: 430
  start-page: 26
  year: 2012
  ident: 10.1016/j.ijpharm.2016.02.030_bib0080
  article-title: Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2012.03.020
  contributor:
    fullname: Kubavat
– ident: 10.1016/j.ijpharm.2016.02.030_bib0090
– volume: 33
  start-page: 435
  year: 1993
  ident: 10.1016/j.ijpharm.2016.02.030_bib0105
  article-title: Renal toxicity of the nonsteroidal anti-Inflammatory drugs
  publication-title: Annu. Rev. Pharmacol. Toxicol.
  doi: 10.1146/annurev.pa.33.040193.002251
  contributor:
    fullname: Murray
– ident: 10.1016/j.ijpharm.2016.02.030_bib0035
– volume: 11
  start-page: 1642
  year: 2010
  ident: 10.1016/j.ijpharm.2016.02.030_bib0125
  article-title: Micronization of a soft material: air-Jet and micro-Ball milling
  publication-title: AAPS PharmSciTech
  doi: 10.1208/s12249-010-9542-5
  contributor:
    fullname: Saleem
– volume: 4
  start-page: 1047
  year: 2010
  ident: 10.1016/j.ijpharm.2016.02.030_bib0185
  article-title: Production of new haemostatic materials by deposition of dispersed proteins onto porous matrices using supercritical carbon dioxide
  publication-title: Russ. J. Phys. Chem. B
  doi: 10.1134/S1990793110070018
  contributor:
    fullname: Zalepugin
– volume: 6
  start-page: 773
  year: 2012
  ident: 10.1016/j.ijpharm.2016.02.030_bib0015
  article-title: Coverage of prandial insulin requirements by means of an ultra-Rapid-Acting inhaled insulin
  publication-title: J. Diabetes Sci. Technol.
  doi: 10.1177/193229681200600406
  contributor:
    fullname: Boss
– volume: 88
  start-page: 23
  year: 2003
  ident: 10.1016/j.ijpharm.2016.02.030_bib0060
  article-title: A new agglomerated KSR-592 beta-form crystal system for dry powder inhalation formulation to improve inhalation performance in vitro and in vivo
  publication-title: J. Controlled Release
  doi: 10.1016/S0168-3659(02)00460-1
  contributor:
    fullname: Ikegami
– volume: 41
  start-page: 1107
  year: 2013
  ident: 10.1016/j.ijpharm.2016.02.030_bib0170
  article-title: Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
  publication-title: Eur. Respir. J.
  doi: 10.1183/09031936.00071312
  contributor:
    fullname: Wilson
– ident: 10.1016/j.ijpharm.2016.02.030_bib0065
– volume: 41
  start-page: 64
  year: 2013
  ident: 10.1016/j.ijpharm.2016.02.030_bib0075
  article-title: Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review
  publication-title: Phys. Sportsmed.
  doi: 10.3810/psm.2013.05.2016
  contributor:
    fullname: Klinge
– volume: 362
  start-page: 235
  year: 2013
  ident: 10.1016/j.ijpharm.2016.02.030_bib0155
  article-title: Crystalline coats or hollow crystals as tools for product design in pharmaceutical industry
  publication-title: J. Cryst. Growth
  doi: 10.1016/j.jcrysgro.2011.10.060
  contributor:
    fullname: Ulrich
– volume: 48
  start-page: 107
  year: 2011
  ident: 10.1016/j.ijpharm.2016.02.030_bib0100
  article-title: The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine
  publication-title: J. Clin. Biochem. Nutr.
  doi: 10.3164/jcbn.10-79
  contributor:
    fullname: Matsui
– volume: 96
  start-page: 1302
  year: 2007
  ident: 10.1016/j.ijpharm.2016.02.030_bib0045
  article-title: Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.20943
  contributor:
    fullname: Hickey
– volume: 27
  start-page: 2131
  year: 2010
  ident: 10.1016/j.ijpharm.2016.02.030_bib0055
  article-title: Inhalation performance of physically mixed dry powders evaluated with a simple simulator for human inspiratory flow patterns
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-010-0215-6
  contributor:
    fullname: Hira
– volume: 343
  start-page: 769
  year: 1994
  ident: 10.1016/j.ijpharm.2016.02.030_bib0120
  article-title: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal
  publication-title: Lancet
  doi: 10.1016/S0140-6736(94)91843-0
  contributor:
    fullname: Rodriguez
– volume: 270
  start-page: 297
  year: 2004
  ident: 10.1016/j.ijpharm.2016.02.030_bib0135
  article-title: Alternative sugars as potential carriers for dry powder inhalations
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2003.10.039
  contributor:
    fullname: Steckel
– volume: 34
  start-page: 1422
  year: 2005
  ident: 10.1016/j.ijpharm.2016.02.030_bib0175
  article-title: A simple route to form straw-like carbon microbundles
  publication-title: Chem. Lett.
  doi: 10.1246/cl.2005.1422
  contributor:
    fullname: Xiao
– volume: 51
  start-page: 2385
  year: 1995
  ident: 10.1016/j.ijpharm.2016.02.030_bib0020
  article-title: Aqueous infrared carboxylate absorbances: aliphatic monocarboxylates
  publication-title: Spectrochim. Acta. A. Mol. Biomol. Spectrosc.
  doi: 10.1016/0584-8539(95)01479-9
  contributor:
    fullname: Cabaniss
– volume: 26
  start-page: 5475
  year: 2010
  ident: 10.1016/j.ijpharm.2016.02.030_bib0005
  article-title: Evaluation of the BET method for determining surface areas of MOFs and zeolites that contain ultra-Micropores
  publication-title: Langmuir
  doi: 10.1021/la100449z
  contributor:
    fullname: Bae
– volume: 25
  start-page: 389
  year: 2008
  ident: 10.1016/j.ijpharm.2016.02.030_bib0010
  article-title: Surface morphology of spray-dried nanoparticle-coated microparticles designed as an oral drug delivery system
  publication-title: Braz. J. Chem. Eng.
  doi: 10.1590/S0104-66322008000200016
  contributor:
    fullname: Beck
– volume: 50
  start-page: 979
  year: 2007
  ident: 10.1016/j.ijpharm.2016.02.030_bib0095
  article-title: Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms
  publication-title: J. Med. Chem.
  doi: 10.1021/jm0612970
  contributor:
    fullname: Llinàs
SSID ssj0006213
Score 2.3478744
Snippet [Display omitted] To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of...
To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled...
OBJECTIVETo crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 170
SubjectTerms Anti-Inflammatory Agents, Non-Steroidal - chemistry
Calorimetry, Differential Scanning
Crystallization
Diclofenac
Diclofenac - chemistry
Diclofenac sodium
Drug Delivery Systems
Dry powder inhaler
Dry Powder Inhalers
Jet milling
Microscopy, Electron, Scanning
Next generation impactor
Particle Size
Powder Diffraction
Powders
Precipitation
Spectroscopy, Fourier Transform Infrared
Technology, Pharmaceutical
X-Ray Diffraction
Title Hollow crystalline straws of diclofenac for high-dose and carrier-free dry powder inhaler formulations
URI https://dx.doi.org/10.1016/j.ijpharm.2016.02.030
https://www.ncbi.nlm.nih.gov/pubmed/26911418
https://search.proquest.com/docview/1774533535
Volume 502
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFBehvexSum7t0i80GD3ViS1ZtnwspSXbIBTWQm_ixZJYArWDnRJy2d_e9_zRUOgY7GghyUI_6b2fpPfB2LdUOQCRy8ArHQaxoPdd5ekOHrm21t4r2xjITpPJQ_zjUT0O2HXvC0NmlZ3sb2V6I627knE3m-PlfD7-FcomsbxERtF4fJIHO6o_XNOjP1szj0R0KZLxtES1t14848VovlhSgGiy8Eqa0J1kDP2-fvob_2z00O0-2-sIJL9qx_iRDVxxwC7u2gjUm0t-v3Woqi_5Bb_bxqbefGJ-griXa55XG6SFFI_bcbrsWNe89Nxil6V3BeQcuSynUMaBLWvHobA8h4qy2wW-co7basOX5dq6is-L36hkKmrx1OUCqz-zh9ub--tJ0KVaCHJkEKtAyJnMvU4FMoQwty72Hg9nswzCBISVPosgg8x5iBxoDbFXEHqHJ1mrQEcqlYdspygL94XxNMuxmkiFjHWskO8AbnEsgZC8VuNkyEb9BJtlG1HD9KZmC9MhYggREwqDiAyZ7mEwb5aGQan_r6Zfe9gMbht6C4HClc-1iZD2ItNVUg3ZUYvn62hEghogjvTx___4hH2gL3p2iqJTtrOqnt0ZspfV7LxZnuds9-r7z8n0Bes677k
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT9swFLYYHLbLBIxt5cfwJMSJ0MSOE-eI0FAYrEKiSNys19jWWmlJlRRV_e95ThwqJKZJuzpxYvmznz_b732PkJNUGABW8MAKGQYxc_e7wrozeOTaUlordOsgO0ryh_jno3jcIJd9LIxzq_S2v7PprbX2JUPfm8P5dDq8D3mbWJ4jo2gjPt-RLWQDGc7OrYvrm3z0YpAT5rMk44bJVVgH8gxn59PZ3GlEOyevpFXvdP7Qby9Rf6Og7VJ0tU0-eg5JL7pm7pANU-6S07tOhHp1RsfrmKrmjJ7Su7U89eoTsTlCXy1pUa-QGTpJbkPdeceyoZWlGj9ZWVNCQZHOUqdmHOiqMRRKTQuoXYK7wNbGUF2v6LxaalPTafkb15na1fjj04E1e-Th6sf4Mg98toWgQBKxCBif8MLKlCFJCAttYmtxfzbJIEyAaW6zCDLIjIXIgJQQWwGhNbiZ1QJkJFL-mWyWVWm-EppmBb7GUsZjGQukPICzHEsgdIGrcTIg530Hq3knqqF6b7OZ8ogoh4gKmUJEBkT2MKhXo0Oh4f9X1e89bApnjrsOgdJUT42KkPki2RVcDMiXDs-X1jAcR1Ecyf3___ExeZ-Pf92q2-vRzQH54J64W6goOiSbi_rJHCGZWUy--cH6DCk78m0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hollow+crystalline+straws+of+diclofenac+for+high-dose+and+carrier-free+dry+powder+inhaler+formulations&rft.jtitle=International+journal+of+pharmaceutics&rft.au=Yazdi%2C+Ashkan+K.&rft.au=Smyth%2C+Hugh+D.C.&rft.date=2016-04-11&rft.issn=0378-5173&rft.volume=502&rft.issue=1-2&rft.spage=170&rft.epage=180&rft_id=info:doi/10.1016%2Fj.ijpharm.2016.02.030&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ijpharm_2016_02_030
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-5173&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-5173&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-5173&client=summon